Companies Related to "AMAG Pharmaceuticals Participate Barclays High Yield Bond Syndicated" [Most Relevant Company Matches] RSS

19:36 EDT 22nd March 2018 | BioPortfolio

Here are the most relevant search results for "AMAG Pharmaceuticals Participate Barclays High Yield Bond Syndicated" found in our extensive corporate database of over 50,000 company records.

Showing "AMAG Pharmaceuticals Participate Barclays High Yield Bond Syndicated" Companies 1–25 of 5,900+

Extremely Relevant

AMAG Pharmaceuticals, Inc.


Bond Laboratories, Inc.

Bond Laboratories is a manufacturer of innovative nutritional supplements and beverages. The Company produces and markets products through its NDS Nutrition and Fusion Premium Beverages divisions. NDS nutritional supplements are among the most popular products sold in GNC® franchise retail stores. Fusion Premium Beverages manufactures functional beverag...

Cairns Bond Ltd

Welcome to our website and thank you for showing an interest in Cairns Bond, an executive search and recruitment firm based in Edinburgh, Scotland.Cairns Bond undertakes recruitment assignments to identify and select key executives for senior and middle-level positions in:- general management accountancy and taxation law corporate finance corporate strategy and development financial services Amo...

Bond International Software

Bond (UK, AIM:BDI) is the world’s leading supplier of staffing and recruitment software, with offices in the US, UK, Hong Kong, Japan, Australia and South Africa. Its fully configurable flagship product, Adapt, supports over 100,000 staffing professionals in 42 countries worldwide. For more information please call (800) 882 BOND or visit



Gold Bond

Gold Bond is a leading therapeutic skin care brand providing new and noticeably better solutions that help get skin back to healthy. With a trusted heritage of healing skin problems since 1908, Gold Bond offers a broad line of products including some of the fastest-growing hand and body lotions, as well as the top-selling medicated body powder, foot powder, foot cream and foot pain cream in Americ...

Yield Pharma

Yield Pharma, located in Suzhou, China, is a biochemistry company providing amino acids, chiral compounds, building blocks and intermediaries for pharmaceutical applications. Our clients are mainly life science companies in USA and EU.E2INF is our corporate working culture. E2 - Effectiveness and Efficiency, I - Integrity, N - Novelty, F - Flexibility. Yield employees are highly committed to acc...

Cold Genesys Inc.

Cold Genesys, Inc. is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. In 2010, Cold Genesys acquired exclusive worldwide rights to develop CG0070 from BioSante Pharmaceuticals. CG0070 is currently under investigation in a Phase II, single-arm, open-label, pivotal study (BOND II) for patient...

Spray Nine

Spray Nine is distributed by Permatex, a leading manufacturer, distributor, and marketer of premium chemical products to commercial, industrial and consumer markets. Since 1909, Permatex has been an acknowledged leader in the development of innovative new products and services for the automotive aftermarket. Permatex markets a wide range of products under ...


LookSmart provides relevant content, advertising and technology solutions for consumers, advertisers and publishers. LookSmart's 180+ vertical search sites are where consumers look for what they need, offering essential search results and web tools to find, save and share articles. In addition to proprietary vertical properties, LookSmart's advertiser distribution network includes syndicated publi...

Nanotherapeutics, Inc

Nanotherapeutics, Inc. (“Nanotherapeutics”), a Florida Corporation, has made new discoveries in the area of nanotechnology and is applying them to the development of novel drug therapies. Nanotherapeutics has developed three proprietary drug delivery technologies, NanoDRYTM, NanoQUADTM, and NanoCOATTM; which produce improved pharmaceuticals at high yield that are substantially more versatile a...

Inverseon, Inc.

Inverseon's product development programs target significant unmet medical needs and major market opportunities in chronic pulmonary diseases such as asthma, COPD and pulmonary hypertension. Inverseon was founded based on the original work of Prof. Richard Bond of the University of Houston. Professor Bond termed the effects “Paradoxical Pharmacologyâ...

Spinal Elements, Inc.

Spinal Elements, headquartered in Carlsbad, CA, is a spine technology company for spine surgeons who demand innovative, extremely high quality surgical solutions. From the company’s early work which helped make PEEK commonplace throughout the spine industry to recent advancements in Ti-Bond® porous titanium coated PEEK interbody implants and controlled ...

Spectacular Bond

Bond International Software plc

BankInvest International

BankInvest is a focused investment boutique that specialises in high return and high yield asset classes. As Denmark's third largest and fastest growing asset manager, its range of products includes global equities, bonds, structured products and venture. These all share the common denominator that we add value to them by bringing specialist and expert knowledge to the due diligence and valuation ...

Transparency Market Research

Transparency Market Research (TMR) is a U.S.-based market intelligence company driven by a global team of high-pedigree industry consultants, analysts, and researchers. TMR leverages its worldwide Syndicated Research, Custom Research, and Market Consulting expertise to help businesses make accurate decisions.

NimbleGen Systems Inc.

NimbleGen Systems, the leading supplier of flexible high-density microarray products and services, is enabling a new era of "High-Definition GenomicsSM." NimbleGen uniquely produces high-density arrays of isothermal long oligos that provide superior results for advanced genomic analysis methods such as CGH, ChIP, microbial whole-genome resequencing and expression tiling. NimbleGen's High-Definitio...

Human Animal Bond Research Initiative Foundation

BEE International

BEE International is a worldwide supplier of high pressure homogenizing systems to the Pharmaceutical and Biotech industries. Cell lysis applications benefit from a the highest yield in the fewest passes. Emulsions, dispersion and nanoparticle applications benefit from a tight distribution of small particles. We are dedicated to advancing the technology of homogenization to give our customers the...

Esay Solutions

eSAY develop answers for business problems. As a complete IT consultancy, we offer our clients the opportunity to improve their business through the application of tailored IT products. We have helped clients in a number of widely differing industries including new media , Internet service providers , engineering firms, retailers all the way through to providing consultancy services to blue-chip ...

Apexian Pharmaceuticals

Apexian Pharmaceuticals is a clinical-stage biotechnology company focused on developing safe and effective therapy for patients with high unmet medical needs. Apexian’s lead drug candidate APX3330, is an oral first-in-class novel inhibitor of the APE1 protein, a critical node in cancer cell signaling. To learn more about Apexian Pharmaceuticals, pleas...

McGladrey Capital Markets LLC

Highland Capital Management, L.P. is a SEC-registered investment adviser with approximately $22 billion of assets under management. It is one of the largest global alternative fixed income managers, specializing in bank loans, high yield credit, distressed debt, structured products, real assets, and long-short equities, with a global geographic reach.

Univec, Inc.

Univec, Inc., a minority business enterprise (MBE), is a Specialty Pharmaceutical Company that manufactures and distributes high cost Specialty Pharmaceuticals. Specialty Pharmaceuticals are high cost products that are not usually dispensed in retail pharmacies but require special handling and a complex pharmaceutical regime. The company is focused on dise...

Azelon Pharmaceuticals, Inc.

Azelon Pharmaceuticals is focused on the development of novel formulations for the treatment of osteoporosis. Its lead program, ZT-034, a nasal spray formulation of teriparatide (PTH1-34), offers a convenient alternative for patients at high risk of fracture. Led by an experienced team of biopharmaceutical executives and funded by leading venture cap...

More From BioPortfolio on "AMAG Pharmaceuticals Participate Barclays High Yield Bond Syndicated"

Quick Search


Corporate Database Quicklinks